California Public Employees Retirement System boosted its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 24.9% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 1,155,532 shares of the company’s stock after acquiring an additional 230,183 shares during the quarter. California Public Employees Retirement System’s holdings in Avantor were worth $9,059,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the stock. EverSource Wealth Advisors LLC lifted its holdings in shares of Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after acquiring an additional 1,189 shares during the last quarter. Private Trust Co. NA increased its holdings in Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares during the last quarter. Strategic Wealth Investment Group LLC acquired a new stake in Avantor in the 2nd quarter valued at approximately $32,000. Los Angeles Capital Management LLC purchased a new stake in Avantor in the fourth quarter valued at approximately $32,000. Finally, Osaic Holdings Inc. raised its position in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Avantor
In related news, Director Simon Dingemans purchased 25,000 shares of Avantor stock in a transaction on Friday, May 1st. The shares were bought at an average price of $8.14 per share, with a total value of $203,500.00. Following the transaction, the director directly owned 25,000 shares of the company’s stock, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gregory T. Lucier acquired 10,000 shares of the firm’s stock in a transaction dated Friday, May 8th. The stock was bought at an average price of $8.32 per share, with a total value of $83,200.00. Following the purchase, the director directly owned 60,000 shares in the company, valued at approximately $499,200. This trade represents a 20.00% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.28% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on AVTR
Avantor Stock Up 1.0%
Avantor stock opened at $11.47 on Friday. The firm has a market capitalization of $7.83 billion, a P/E ratio of -14.16, a P/E/G ratio of 6.37 and a beta of 0.94. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68. Avantor, Inc. has a twelve month low of $7.26 and a twelve month high of $15.93. The stock’s fifty day simple moving average is $9.71 and its 200-day simple moving average is $9.41.
Avantor (NYSE:AVTR – Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.Avantor’s revenue was up .0% compared to the same quarter last year. During the same period last year, the business posted $0.23 earnings per share. As a group, equities analysts expect that Avantor, Inc. will post 0.79 earnings per share for the current fiscal year.
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Stories
- Five stocks we like better than Avantor
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
